BRITTANY SMITH: Open Payments
NPI 1982006078 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 16 payments from 11 companies in 2025. Trend: 2023 $310 · 2024 $45 · 2025 $543
Food & beverage: $343Education: $200
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $147 |
| Janssen Biotech, Inc. | 2 | $122 |
| Merck Sharp & Dohme LLC | 3 | $84 |
| PharmaEssentia USA Corporation | 1 | $33 |
| Coherus Oncology, Inc. | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $25 |
| Eisai Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $24 |
| Viatris Specialty LLC | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
Products named: DARZALEX, LYNPARZA, KEYTRUDA, IMFINZI, BESREMI, LOQTORZI, Trodelvy, Lenvima.
Industry payments across GA — which companies pay providers there.
